Drugs / Sandimmun Optoral
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 3 | NCT00514514 | Jul 2007 → Jun 2015 | — | Novartis Pharmaceuticals | Completed | Met primary |
Evidence & citations 1 cited value
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Sandimmun Optoral | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00514514 ↗ |